Aroa Biosurgery【ARX】銘柄情報

Aroa Biosurgery Limited (ARX) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.60

( 0.84% )

買値

0.595

売値

0.61

出来高

4,480

0.60 日の範囲 0.60

0.495 52 週間の範囲 0.80

時価総額

207.542M

前日終値

0.595

始値

0.60

時刻

1033

0.6

最終取引時間

08:59:13

財務取引量

VWAP

平均取引量 (3 か月)

AUD 213,911

発行済株式数

345,902,653

配当利回り

PER

55.9

1 株当たり利益 (EPS)

0.01

歳入

103.85M

純利益

4.68M

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute... Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

aroa.com

本社

Auckland, New Zealand

設立

2026

Aroa Biosurgery Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ARX. The last closing price for Aroa Biosurgery was AUD0.60. Over the last year, Aroa Biosurgery shares have traded in a share price range of AUD 0.495 to AUD 0.80.

Aroa Biosurgery currently has 345,902,653 shares in issue. The market capitalisation of Aroa Biosurgery is AUD207.54 million. Aroa Biosurgery has a price to earnings ratio (PE ratio) of 55.90.

Real-World Data Shows Aroa Biosurgery’s Endoform™ Natural Achieves Significantly Improved Wound Closure for Diabetic Foot Ulcers Compared to Traditional Collagen Dressings

Highlights A retrospective analysis of real-world data published in the ‘International Wound Journal’ compared the wound closure times for...

Aroa Biosurgery Launches New Product, Myriad Morcells™ - Offering Highly Conformable Tissue Regeneration in Wound Beds - Fo...

HIGHLIGHTS Soft tissue regeneration company Aroa Biosurgery Limited has this week launched a new product named Myriad Morcells™, a morcellized...

New U.S. Clinical Studies Provide Further Validation for Aroa Biosurgery’s Myriad™, as Products Also Approved for Use in ...

HIGHLIGHTS Further validation for Aroa’s Myriad™ from two clinical studies and peer-reviewed publications in Journal of Wound Care. One study...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.015	2.5641025641	0.585	0.6	0.58	203655	0.58887804	DE
4	-0.075	-11.1111111111	0.675	0.675	0.58	206115	0.61564126	DE
12	0.055	10.0917431193	0.545	0.7	0.495	222919	0.60761936	DE
26	-0.125	-17.2413793103	0.725	0.775	0.495	171359	0.63140917	DE
52	0.03	5.26315789474	0.57	0.8	0.495	206927	0.66000819	DE
156	-0.33	-35.4838709677	0.93	9.4	0.35	310518	0.61421385	DE
260	-0.51	-45.9459459459	1.11	9.4	0.35	297867	0.75460186	DE